Effects of surgeon volume and hospital volume on clinical outcomes of breast cancer patients

  • Mariia Pavlushenko Department of Oncology, O.O. Bogomolets National Medical University, Kyiv 03115
  • Roman Liubota Department of Oncology, O.O. Bogomolets National Medical University, Kyiv 03115
  • Roman Vereshchako Department of Oncology, O.O. Bogomolets National Medical University, Kyiv 03115
  • Mykola Anikusko Municipal City Clinical Oncological Centre, Kyiv 03115
  • Iryna Liubota Department of Oncology, O.O. Bogomolets National Medical University, Kyiv 03115; Municipal City Clinical Oncological Centre, Kyiv 03115
Keywords: Surgeon volume, Hospital volume, Breast cancer, Cancer care, Cancer treatment, Breast cancer-specific mortality, Survival

Abstract


cancer has become the leading cause of global cancer in the female population, ahead of lung cancer. Over the past half century, approach to the treatment of breast cancer has changed dramatically that led to improvement of survival rates and quality of life of patients. In particular, the changes affected the surgical treatment of breast cancer. The modern tactics of treating breast cancer patients has become more complex and requires a multidisciplinary approach led by an oncological surgeon. It requires the availability of specialized material and equipment in medical institutions and practical skills of surgeons that provide medical care to breast cancer patients. However, breast cancer patients may not receive the entire range of modern treatment options, due to limited capabilities of medical institution and/or surgeon that leads to deterioration in duration and quality of life of patients. The quality of medical care for breast cancer patients is directly proportional to the number of cases performed annually at a medical institution (hospital volume) or by a surgeon (surgeon volume). The results of this study can serve as a basis for further investigations of the relationship between the surgeon and hospital volume and other factors affecting the quality and diversity of medical care for breast cancer patients.

References

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660.

Liubota R, Cheshuk V, Vereshchako R, Zotov O, Zaichuk V, Anikusko N, Liubota I. The impact of locoregional treatment on survival of patients with primary metastatic breast cancer. Exp Oncol. 2017 Mar;39(1):75-77.

Greenup RA, Obeng-Gyasi S, Thomas S, Houck K, Lane WO, Blitzblau RC, et al. The Effect of Hospital Volume on Breast Cancer Mortality. Ann Surg. 2018 Feb;267(2):375-381. doi: 10.1097/SLA.0000000000002095.

Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ. 2012 Apr 26;344:e2718. doi:10.1136/bmj.e2718.

Skinner KA, Helsper JT, Deapen D, Ye W, Sposto R. Breast cancer: do specialists make a difference? Ann Surg Oncol. 2003 Jul;10(6):606-15. doi: 10.1245/aso.2003.06.017.

Nattinger AB, Laud PW, Sparapani RA, Zhang X, Neuner JM, Gilligan MA. Exploring the surgeon volume outcome relationship among women with breast cancer. Arch Intern Med. 2007 Oct 8;167(18):1958-63. doi:10.1001/archinte.167.18.1958.

Gilligan MA, Neuner J, Sparapani R, Laud PW, Nattinger AB. Surgeon characteristics and variations in treatment for early-stage breast cancer. Arch Surg. 2007 Jan;142(1):17-22. doi: 10.1001/archsurg.142.1.17.

Chang CM, Huang KY, Hsu TW, Su YC, Yang WZ, Chen TC, et al. Multivariate analyses to assess the effects of surgeon and hospital volume on cancer survival rates: a nationwide population-based study in Taiwan. PLoS One. 2012;7(7):e40590. doi:10.1371/journal.pone.0040590.

Pezzin LE, Laud P, Yen TW, Neuner J, Nattinger AB. Reexamining the Relationship of Breast Cancer Hospital and Surgical Volume to Mortality: An Instrumental Variable Analysis. Med Care. 2015 Dec;53(12):1033-9. doi:10.1097/MLR.0000000000000439.

Simunovic M, Rempel E, Thériault ME, Coates A, Whelan T, Holowaty E, Langer B, Levine M. Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario. Can J Surg. 2006 Aug;49(4):251-8.

Kuo RN, Chung KP, Lai MS. Re-examining the significance of surgical volume to breast cancer survival and recurrence versus process quality of care in Taiwan. Health Serv Res. 2013 Feb;48(1):26-46. doi: 10.1111/j.1475-6773.2012.01430.x.

Vrijens F, Stordeur S, Beirens K, Devriese S, Van Eycken E, Vlayen J. Effect of hospital volume on processes of care and 5-year survival after breast cancer: a population-based study on 25000 women. Breast. 2012 Jun;21(3):261-6. doi:10.1016/j.breast.2011.12.002.

Yen TW, Pezzin LE, Li J, Sparapani R, Laud PW, Nattinger AB. Effect of hospital volume on processes of breast cancer care: A National Cancer Data Base study. Cancer. 2017 May 15;123(6):957-966. doi: 10.1002/cncr.30413.

Garcia-Etienne CA, Mansel RE, Tomatis M, Heil J, Biganzoli L, Ferrari A, et al.; EUSOMA Working Group. Trends in axillary lymph node dissection for early-stage breast cancer in Europe: Impact of evidence on practice. Breast. 2019 Jun;45:89-96. doi: 10.1016/j.breast.2019.03.002.

Wyld L, Rubio IT, Kovacs T. Education and Training in Breast Cancer Surgery in Europe. Breast Care (Basel). 2019;14(6):366-372. doi:10.1159/000502638

AM, Wall DM, Waters PS, Cheung S, Sibbering M, Horgan K, et al. ABS Audit Committee. Surgeon and breast unit volume-outcome relationships in breast cancer surgery and treatment. Ann Surg. 2013 Nov;258(5):808-13; discussion 813-4. doi:10.1097/SLA.0b013e3182a66eb0.

Biganzoli L, Cardoso F, Beishon M, Cameron D, Cataliotti L, Coles CE, et al. The requirements of a specialist breast centre. Breast. 2020 Jun;51:65-84. doi:10.1016/j.breast.2020.02.003.

Published
2022/08/12
Section
Review Paper